Sponsors

Screening for HIV right at the point of care

It is estimated that there were 4.3 million new cases of human immunodeficiency virus (HIV) in 2006 and half a million of these were children under 15 years old. Around 40 million people worldwide are now living with HIV/AIDS, so early detection and treatment of HIV-1 and -2 remains critical in improving survival rates and reducing transmission, especially to the unborn child.

Point-of-care testing is recommended for all healthcare settings, including emergency rooms and prenatal clinics, where HIV carriers could be present. With its new Clearview Complete HIV 1/2 kit, Inverness Medical makes screening and follow-up easier than ever before. Everything needed is included in one sealed, easy-to-use test pack for sampling, testing and analysing the sample – test, reagent, lancet and even the bandage (Elastoplast).

Clearview Complete HIV 1/2 screens for HIV-1 and -2 antibodies in whole blood, serum or plasma using proven lateral-flow technology. The high sensitivity of the test kit delivers reliable results in as little as 15 minutes. This means the patient is still present when results appear, enabling rapid follow-up and counselling if required. Clearview Complete HIV 1/2 kits have a shelf life of 24 months and can be stored at room temperature.

Inverness Medical Tel: +44 (0)1234 835229 www.invmed.com

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024